Logo Valence
Populaire
Se connecter
Loading data for GT — first visit, this takes a few seconds.

Ajouter à la liste de suivi

n/a

NasdaqGS: GT · Prix en temps réel · USD
6.15
-0.11 (-1.76%)
À la clôture : Aug 27, 2026, 2:44 PM

Le cours, les chiffres clés et les dernières actualités, au même endroit.

(GT) : cours, analyse et données

-1.76%

Aucune donnée disponible

Cours acheteur5.31
Capitalisation boursière1.78B
Chiffre d’affaires (ttm)n/a
Résultat net (ttm)n/a
n/a
-8.84
n/a
n/a
P/B (ttm)n/a
P/S (ttm)n/a
Date des résultatsn/a
Cours vendeur7.05
Volume5,412,037
Volume moy. (20D)9,827,096
Ouverture6.23
Clôture précédente6.26
Fourchette du jour6.12 - 6.25
Intervalle de 52 semaines5.43 - 10.62
Analysten/a
Objectif de prixn/a
Dividendesn/a
Date ex-dividenden/a

À propos de GT

A detailed description of the company is not yet available....

[En savoir plus]
Industrie n/a
Secteur n/a
Date d’introduction n/a
Employés n/a
Bourse n/a
Symbole boursier GT
Profil complet de l’entreprise

Surprise sur les résultats

a publié ses résultats trimestriels le Aug 5, 2026 :
  • Chiffre d’affaires de $4.25B est inférieur aux estimations de $0, avec -4.82% Baisse en glissement annuel.
  • EPS de -0.61 dépasse les estimations de 0.02, avec -258.82% Baisse en glissement annuel.
news image

6 jours il y a · 24/7 Wall St.

The Rise and Fall of America’s Tire Dynasty: Four Brands Bought by Foreign Giants and the One Titan Left

For decades, Akron's rubber barons supplied tires to nearly every car rolling off an American assembly line, building an industrial empire so dominant it seemed untouchable. Then a French patent filed...

news image

1 semaine il y a · StockStory

3 Cash-Producing Stocks Walking a Fine Line

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

news image

1 semaine il y a · Benzinga

Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'

China has pulled ahead of the United States in clinical drug development and supply chain, two of six domains measured in a June Cure Innovation Index survey, even as Big Pharma signs billion-dollar d...

news image

1 semaine il y a · StockStory

The Top 5 Analyst Questions From AerSale’s Q2 Earnings Call

AerSale’s second quarter results were met with a significant negative reaction from the market, as both revenue and profitability fell well short of Wall Street’s expectations. Management attributed t...

news image

1 semaine il y a · StockStory

5 Revealing Analyst Questions From Goodyear’s Q2 Earnings Call

Goodyear’s second quarter saw global sales fall in line with broader industry softness, with the market reacting negatively to ongoing margin pressure and a continued year-over-year revenue decline. M...

Page 1 de 2